Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study
# Background Pre-exposure prophylaxis (PrEP) for COVID-19 provides additional protection, beyond vaccines alone, for individuals who are immunocompromised (IC). This may reduce the need for preventative behavioral modification, such as shielding—a behavioral restriction limiting an IC individual to...
Saved in:
Main Authors: | Katy Gallop, Rebekah Hall, Michael Watt, Daniel Squirrell, Neil Branscombe, Sofie Arnetop, Andrew Lloyd |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.120605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Florida’s Urban Forest: A Valuation of Benefits
by: Drew C. McLean, et al.
Published: (2020-11-01) -
Florida’s Urban Forest: A Valuation of Benefits
by: Drew C. McLean, et al.
Published: (2020-11-01) -
Benefits of prophylactic voice prosthesis replacement: a retrospective study
by: Sławomir Okła, et al.
Published: (2025-06-01) -
Histoplasmosis in Immunocompromised and Immunocompetent Patients in Guadeloupe
by: Constance Lahuna, et al.
Published: (2025-06-01) -
PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
by: V. V. Ryazhenov, et al.
Published: (2011-06-01)